49
In band
Moving averages
SMA 200$15.56+7.01%
Company profile
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.
SectorHealthcare
IndustryBiotechnology
Market cap$2.19B
P/E ratio7.21
EPS$2.28
Beta1.611
Dividend yield0.00%
52-week high$19.25
52-week low$11.21
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
NVAX
Novavax Inc
RSI 45
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 54
SRPT
Sarepta Therapeutics Inc
RSI 51
ATAI
ATAI Life Sciences N.V.
RSI 62
NTLA
Intellia Therapeutics Inc
RSI 53
RSI alerts for AUPH
An email when AUPH closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:37 PM EDT